{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:45Z","timestamp":1791928965719,"version":"4.3.4"},"reference-count":27,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"5","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,5,19]]},"DOI":"10.1167\/iovs.67.5.48","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:30:44Z","timestamp":1779197444000},"page":"48","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced Efficacy of Cefiderocol With PolyTrim Combination Therapy in a Rabbit Model of Extensively Drug-Resistant\n                    <i>Pseudomonas aeruginosa<\/i>\n                    Keratitis"],"prefix":"10.1167","volume":"67","author":[{"given":"Eric G.","family":"Romanowski","sequence":"first","affiliation":[{"name":"The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Vision Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily K.","family":"Young","sequence":"additional","affiliation":[{"name":"The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Vision Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Mandell","sequence":"additional","affiliation":[{"name":"The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Vision Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepinder K.","family":"Dhaliwal","sequence":"additional","affiliation":[{"name":"The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Vision Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Mammen","sequence":"additional","affiliation":[{"name":"The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Vision Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Jhanji","sequence":"additional","affiliation":[{"name":"The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Vision Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Zegans","sequence":"additional","affiliation":[{"name":"Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M. Q.","family":"Shanks","sequence":"additional","affiliation":[{"name":"The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Vision Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"2","key":"bib1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s40123-021-00449-9","article-title":"A systematic review of multi-decade antibiotic resistance data for ocular bacterial pathogens in the United States","volume":"11","author":"Bispo","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"108647","DOI":"10.1016\/j.exer.2021.108647","article-title":"Foundational concepts in the biology of bacterial keratitis","volume":"209","author":"Ung","year":"2021","journal-title":"Exp Eye Res"},{"issue":"5","key":"bib3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/ICL.0000000000000642","article-title":"The prevalence of bacteria, fungi, viruses, and Acanthamoeba from 3,004 cases of keratitis, endophthalmitis, and conjunctivitis","volume":"46","author":"Kowalski","year":"2020","journal-title":"Eye Contact Lens"},{"issue":"6","key":"bib4","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/bjophthalmol-2021-320203","article-title":"Multidrug-resistant keratitis: challenging yet manageable","volume":"107","author":"Sahoo","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"bib5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1099\/jmm.0.001110","article-title":"Pseudomonas aeruginosa and microbial keratitis","volume":"69","author":"Hilliam","year":"2020","journal-title":"J Med Microbiol"},{"issue":"10","key":"bib6","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1016\/j.ophtha.2015.06.007","article-title":"Multidrug-resistant Pseudomonas aeruginosa keratitis: risk factors, clinical characteristics, and outcomes","volume":"122","author":"Vazirani","year":"2015","journal-title":"Ophthalmology"},{"issue":"1","key":"bib7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1167\/iovs.14-15241","article-title":"Correlation of Pseudomonas aeruginosa genotype with antibiotic susceptibility and clinical features of induced central keratitis","volume":"56","author":"Shen","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"bib8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00417-015-3208-7","article-title":"Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome","volume":"254","author":"Fernandes","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"bib9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12348-021-00268-w","article-title":"Virulence factors in multidrug (MDR) and pan-drug resistant (XDR) Pseudomonas aeruginosa: a cross-sectional study of isolates recovered from ocular infections in a high-incidence setting in southern India","volume":"11","author":"Naik","year":"2021","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"101909","DOI":"10.1016\/j.ajoc.2023.101909","article-title":"Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears","volume":"32","author":"Rezaei","year":"2023","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"2","key":"bib12","doi-asserted-by":"publisher","first-page":"e0118823","DOI":"10.1128\/mra.01188-23","article-title":"Genome sequence generated by hybrid Nanopore-Illumina assembly of an extensively drug-resistant Pseudomonas aeruginosa strain from a keratitis outbreak","volume":"13","author":"Calvario","year":"2024","journal-title":"Microbiol Resour Announc"},{"issue":"11","key":"bib13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.ophtha.2023.06.003","article-title":"Association of artificial tears with ocular and systemic infection: carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA) outbreak","volume":"130","author":"Velcani","year":"2023","journal-title":"Ophthalmology"},{"issue":"1","key":"bib14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/cid\/ciae052","article-title":"Extensively drug-resistant Pseudomonas aeruginosa outbreak associated with artificial tears","volume":"79","author":"Grossman","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"4","key":"bib15","doi-asserted-by":"publisher","first-page":"100452","DOI":"10.1016\/j.xops.2023.100452","article-title":"Cefiderocol is an effective topical monotherapy for experimental extensively drug-resistant Pseudomonas aeruginosa keratitis","volume":"4","author":"Romanowski","year":"2024","journal-title":"Ophthalmol Sci"},{"issue":"2","key":"bib16","doi-asserted-by":"publisher","first-page":"e0271221","DOI":"10.1128\/spectrum.02712-21","article-title":"In vitro activity of cefiderocol against U.S. and European Gram-negative clinical isolates collected in 2020 as part of the SENTRY Antimicrobial Surveillance Program","volume":"10","author":"Shortridge","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"2","key":"bib17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/13543784.2018.1426745","article-title":"Cefiderocol: a novel siderophore cephalosporin","volume":"27","author":"Choi","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"issue":"10","key":"bib18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3390\/antibiotics13100979","article-title":"The efficacy of topical cefiderocol treatment of experimental extensively drug-resistant Pseudomonas aeruginosa keratitis is dependent upon the state of the corneal epithelium","volume":"13","author":"Romanowski","year":"2024","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"bib19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cmi.2023.08.029","article-title":"Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia: a systematic review and meta-analysis","volume":"30","author":"Karakonstantis","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"bib20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/tvst.14.11.7","article-title":"Combination therapy of cefiderocol and polymyxin B against Pseudomonas aeruginosa keratitis isolates in vitro","volume":"14","author":"Romanowski","year":"2025","journal-title":"Transl Vis Sci Technol"},{"issue":"44","key":"bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/iovs.66.14.19","article-title":"Ceefiderocol and moxifloxacin have additive and synergistic activity against Pseudomonas aeruginosa including an isolate of the 2023 keratitis outbreak","volume":"66","author":"Romanowski","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"bib22","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1167\/iovs.09-5106","article-title":"A quantitative rabbit model of vaccinia keratitis","volume":"51","author":"Altmann","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"bib23","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1021\/acsinfecdis.2c00193","article-title":"Synergy by perturbing the Gram-negative outer membrane: opening the door for Gram-positive specific antibiotics","volume":"8","author":"Wesseling","year":"2022","journal-title":"ACS Infect Dis"},{"issue":"5","key":"bib24","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ajo.2005.01.021","article-title":"The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model","volume":"139","author":"Romanowski","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"bib25","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1111\/j.1755-3768.2010.01897.x","article-title":"Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models","volume":"88","author":"Kowalski","year":"2010","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"bib26","first-page":"103","article-title":"Is there a role for topical penicillin treatment of Staphylococcus aureus keratitis based on elevated corneal concentrations?","volume":"2","author":"Kowalski","year":"2018","journal-title":"J Clin Ophthalmol Optom"},{"issue":"5","key":"bib27","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.ajo.2006.06.006","article-title":"The in vitro impact of moxifloxacin and gatifloxacin concentration (0.5% vs 0.3%) and the addition of benzalkonium chloride on antibacterial efficacy","volume":"142","author":"Kowalski","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"bib11","article-title":"Outbreak of extensively drug-resistant Pseudomonas aeruginosa associated with artificial tears","author":"Centers for Disease Control and Prevention"}],"container-title":["Investigative Ophthalmology &amp; Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.5.48","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:20Z","timestamp":1791927140000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.5.48"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.5.48","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,19]]}}}